Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 10 Jan 2028. The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical…
Opportunity overview
- Project name
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)?
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 10 Jan 2028. The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical…
Who is funding Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)?
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) is funded by National Institutes of Health.
When is the deadline to apply for Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)?
The application deadline is 10 Jan 2028 00:00 (UTC).
Where will the Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) project take place?
The project location(s) are: United States.
How can I apply for Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.